Morgan Stanley’s General Moly, Inc. GMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,500
| Closed | -$1K | – | 7291 |
|
|
2020
Q3 | $1K | Hold |
4,500
| – | – | ﹤0.01% | 6709 |
|
|
2020
Q2 | $1K | Hold |
4,500
| – | – | ﹤0.01% | 6565 |
|
|
2020
Q1 | $1K | Hold |
4,500
| – | – | ﹤0.01% | 6528 |
|
|
2019
Q4 | $1K | Hold |
4,500
| – | – | ﹤0.01% | 6620 |
|
|
2019
Q3 | $1K | Buy |
4,500
+2,500
| +125% | +$625 | ﹤0.01% | 6599 |
|
|
2019
Q2 | $1K | Sell |
2,000
-13,000
| -87% | -$3.73K | ﹤0.01% | 6608 |
|
|
2019
Q1 | $3K | Hold |
15,000
| – | – | ﹤0.01% | 6423 |
|
|
2018
Q4 | $3K | Hold |
15,000
| – | – | ﹤0.01% | 6391 |
|
|
2018
Q3 | $6K | Buy |
15,000
+14,940
| +24,900% | +$5.84K | ﹤0.01% | 6424 |
|
|
2018
Q2 | $0 | Buy |
+60
| New | +$24 | ﹤0.01% | 6810 |
|
|
2016
Q3 | – | Sell |
-35
| Closed | – | – | 6598 |
|
|
2016
Q2 | $0 | Sell |
35
-2,500
| -99% | -$905 | ﹤0.01% | 6745 |
|
|
2016
Q1 | $1K | Hold |
2,535
| – | – | ﹤0.01% | 6502 |
|
|
2015
Q4 | $1K | Buy |
2,535
+1,500
| +145% | +$409 | ﹤0.01% | 6592 |
|
|
2015
Q3 | $0 | Hold |
1,035
| – | – | ﹤0.01% | 6797 |
|
|
2015
Q2 | $1K | Sell |
1,035
-1,001
| -49% | -$712 | ﹤0.01% | 6590 |
|
|
2015
Q1 | $2K | Buy |
2,036
+36
| +2% | +$18 | ﹤0.01% | 6445 |
|
|
2014
Q4 | $2K | Sell |
2,000
-23,200
| -92% | -$13.1K | ﹤0.01% | 6451 |
|
|
2014
Q3 | $19K | Sell |
25,200
-38,207
| -60% | -$37.4K | ﹤0.01% | 6028 |
|
|
2014
Q2 | $73K | Buy |
63,407
+54,156
| +585% | +$56.5K | ﹤0.01% | 5626 |
|
|
2014
Q1 | $9K | Sell |
9,251
-4,066
| -31% | -$4.94K | ﹤0.01% | 6150 |
|
|
2013
Q4 | $18K | Buy |
13,317
+1,962
| +17% | +$2.82K | ﹤0.01% | 5901 |
|
|
2013
Q3 | $19K | Sell |
11,355
-93,338
| -89% | -$168K | ﹤0.01% | 5286 |
|
|
2013
Q2 | $196K | Buy |
+104,693
| New | +$206K | ﹤0.01% | 4853 |
|
Other funds holding GMO
Morgan Stanley's GMO Position: Q4 2020 in Review
Morgan Stanley sold out of General Moly, Inc. (GMO) in Q4 2020, closing a stake of 4,500 shares — an estimated $1K sold.
Morgan Stanley first reported a position in GMO in Q2 2013 and held it in 23 quarters. The position peaked at $196K in Q2 2013. 7 funds tracked by Wall St. Rank hold GMO as of Q4 2020.
- Morgan Stanley reported no remaining General Moly, Inc. position as of Q4 2020 after selling out during the quarter.
- Morgan Stanley sold 4,500 General Moly, Inc. shares in Q4 2020, an estimated $1K.
- Morgan Stanley first reported a position in General Moly, Inc. in Q2 2013 and held it in 23 quarters.
- Morgan Stanley's General Moly, Inc. position peaked at $196K in Q2 2013.
- 7 funds tracked by Wall St. Rank held General Moly, Inc. as of Q4 2020.
Based on Morgan Stanley's 13F filing for Q4 2020, filed 16 Feb 2021.